vagus_nerve_stimulation_for_drug-resistant_epilepsy_in_children

Vagus nerve stimulation for drug-resistant epilepsy in children

Vagus nerve stimulation for drug-resistant epilepsy in children indications.

A Novel Scoring System to Evaluate the Efficacy of Vagus Nerve Stimulation for Pediatric Drug-Resistant Epilepsy 1).

A meta-analysis was performed using relevant research from databases such as PubMed, Embase, Cochrane Online Library, and Clinicaltrials.gov. Studies were selected according to predefined inclusion and exclusion criteria. The quality of studies was evaluated by using the Newcastle-Ottawa Scale (NOS) scale. DRE patients with shorter duration of epilepsy may be better candidates for VNS rather than those who are younger at onset and implantation. Several EEG or heart rhythm complexity (HRV) features may have predictive value but more research is needed 2).


Reduced seizure burden and improved QOL were more often observed in patients implanted at a younger age. The shorter duration of epilepsy was significantly associated with QOL improvement. Adverse effects were transient. Overall positive effects showed VNS to be a safe, well-tolerated and effective adjunctive treatment in most severe drug-resistant epilepsy patients. Implantation at a younger age and shorter duration of epilepsy before implantation could be important predictors of a better outcome. 3).

Seven patients who had previously experienced VNS failure underwent ANT-DBS device implantation. VNS was turned off before DBS device implantation. Monthly seizure counts starting from baseline to 12-18 months after DBS were analyzed. Five (71.3%) of the 7 patients experienced a >50% reduction of seizure counts after DBS; 1 responder reached a seizure-free status after DBS therapy. Of the 2 nonresponders, 1 subject showed improvement in seizure strength and duration, which lessened the impact of the seizures on the patient's quality of life. This is the first study in which favorable outcomes of ANT-DBS surgery were observed in individual patients with refractory epilepsy who had not responded to prior VNS. Further studies with a larger number of subjects and longer follow-up period are needed to confirm the feasibility of ANT-DBS in patients who have previously experienced VNS failure 4).

Preliminary evidence suggests that VNS treatment is effective for seizure reduction and mental development in young participants between 3 and 6 years of age who suffer from intractable epilepsy. However, robust clinical evidence for quantifying the difference of the efficacy and safety of VNS treatment in this specific patient population has yet to be reported.

METHODS/DESIGN: A two-armed, multicenter, randomized, double-blind, prospective trial will be carried out to evaluate whether VNS is beneficial and safe for pediatric epilepsy. Pediatric participants aged between 3 to 6 years old with intractable epilepsy will be recruited and randomly assigned to experimental and control groups with a 1:1 allocation using a computer-generating randomization schedule. Before enrollment, informed consent will be signed by the parents of the participants and the study researchers. Participants in the experimental group will receive electrical stimulation over 24 weeks under standard stimulation parameters. Participants in the control group will not receive any stimulation during the 12 weeks of the double-blind period. The guardians of the participants are required to keep a detailed diary to record seizure activity. Outcome assessments including seizure frequency, Gesell Mental Developmental Scale scores, use of antiepileptic drugs and dosages, and adverse events will be collected at baseline, 6, 12, 18 and/or 24 weeks after electrical stimulation is initiated. The effects of treatment will be analyzed with time and treatment group comparisons.

DISCUSSION: This trial will evaluate quantitative differences in efficacy and safety with/without VNS treatment for pediatric participants aged between 3 to 6 years with intractable epilepsy and will explore whether the current age range of VNS therapy can be expanded 5).

Vagus nerve stimulation for drug-resistant epilepsy in children case series

Berardinelli-Seip syndrome, or congenital generalized lipodystrophy type 2 (CGL2), is characterized by a lack of subcutaneous adipose tissue and precocious metabolic syndrome with insulin resistance, resulting in diabetes, dyslipidaemia, hepatic steatosis, cardiomyopathy, and acanthosis nigricans. Most reported mutations are associated with mild, non-progressive neurological impairment. We describe the clinical and EEG data of a patient with progressive myoclonus epilepsy (PME), CGL2, and progressive neurological impairment, carrying a homozygous BSCL2 nonsense mutation. The patient had epilepsy onset at the age of two, characterized by monthly generalized tonic-clonic seizures. By the age of three, he presented with drug-resistant ongoing myoclonic absence seizures, photosensitivity, progressive neurological degeneration, and moderate cognitive delay. Molecular analysis of the BSCL2 gene yielded a homozygous c.(1076dupC) p.(Glu360*) mutation. Application of a vagus nerve stimulator led to temporary improvement in seizure frequency, general neurological condition, and EEG background activity. Specific BSCL2 mutations may lead to a peculiar CGL2 phenotype characterized by PME and progressive neurodegeneration. Application of a vagus nerve stimulator, rarely used for PMEs, may prove beneficial, if only temporarily, for both seizure frequency and general neurological condition 6)

15: Ji T, Yang Z, Liu Q, Liao J, Yin F, Chen Y, Zou L, Li B, Gao Y, Shu X, Huang S, Gao F, Liang J, Lin SF, Peng J, Song S, Wang J, Che C, Sun W, Tian M, Yang L, Hua Y, Hao Y, Cai L, Li L, Jiang Y. Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial. Trials. 2019 Jan 14;20(1):44. doi: 10.1186/s13063-018-3087-4. PubMed PMID: 30642370; PubMed Central PMCID: PMC6332620.

16: Yan H, Toyota E, Anderson M, Abel TJ, Donner E, Kalia SK, Drake J, Rutka JT, Ibrahim GM. A systematic review of deep brain stimulation for the treatment of drug-resistant epilepsy in childhood. J Neurosurg Pediatr. 2018 Nov 30;23(3):274-284. doi: 10.3171/2018.9.PEDS18417. PubMed PMID: 30544364.

17: Moro-De Faes G, Serrano-Moyano B, Cantarin-Extremera V, Moreno-Vinues B, Garcia-Fernandez M, Perez-Jimenez MA, Rivero-Martin MB, Garcia-Ezquiaga J, Duat-Rodriguez A, Ruiz-Falco Rojas ML. [Ten years' experience with vagus nerve stimulation in a paediatric population]. Rev Neurol. 2018 Nov 16;67(10):382-386. Spanish. PubMed PMID: 30403281.

18: Hachem LD, Yan H, Ibrahim GM. Invasive Neuromodulation for the Treatment of Pediatric Epilepsy. Neurotherapeutics. 2019 Jan;16(1):128-133. doi: 10.1007/s13311-018-00685-1. Review. PubMed PMID: 30378003; PubMed Central PMCID: PMC6361060.

19: Yu R, Park HJ, Cho H, Ko A, Pae C, Oh MK, Kang HC, Kim HD, Park EK, Shim KW, Kim DS, Lee JS. Interregional metabolic connectivity of 2-deoxy-2[(18) F]fluoro-D-glucose positron emission tomography in vagus nerve stimulation for pediatric patients with epilepsy: A retrospective cross-sectional study. Epilepsia. 2018 Dec;59(12):2249-2259. doi: 10.1111/epi.14590. Epub 2018 Oct 28. PubMed PMID: 30370541.

20: Grioni D, Landi A. Does Vagal Nerve Stimulation Treat Drug-Resistant Epilepsy in Patients with Tuberous Sclerosis Complex? World Neurosurg. 2019 Jan;121:251-253. doi: 10.1016/j.wneu.2018.10.077. Epub 2018 Oct 19. PubMed PMID: 30347295.

21: Myers KA, Sivathamboo S, Perucca P. Heart rate variability measurement in epilepsy: How can we move from research to clinical practice? Epilepsia. 2018 Dec;59(12):2169-2178. doi: 10.1111/epi.14587. Epub 2018 Oct 21. Review. PubMed PMID: 30345509.

22: Soleman J, Stein M, Knorr C, Datta AN, Constantini S, Fried I, Guzman R, Kramer U. Improved quality of life and cognition after early vagal nerve stimulator implantation in children. Epilepsy Behav. 2018 Nov;88:139-145. doi: 10.1016/j.yebeh.2018.09.014. Epub 2018 Sep 27. PubMed PMID: 30269032.

23: Pindrik J, Hoang N, Smith L, Halverson M, Wojnaroski M, McNally K, Gedela S, Ostendorf AP. Preoperative evaluation and surgical management of infants and toddlers with drug-resistant epilepsy. Neurosurg Focus. 2018 Sep;45(3):E3. doi: 10.3171/2018.7.FOCUS18220. PubMed PMID: 30173613.

24: Hachem LD, Wong SM, Ibrahim GM. The vagus afferent network: emerging role in translational connectomics. Neurosurg Focus. 2018 Sep;45(3):E2. doi: 10.3171/2018.6.FOCUS18216. Review. PubMed PMID: 30173606.

25: Grioni D, Landi A, Fiori L, Sganzerla EP. Does emergent implantation of a vagal nerve stimulator stop refractory status epilepticus in children? Seizure. 2018 Oct;61:94-97. doi: 10.1016/j.seizure.2018.08.008. Epub 2018 Aug 11. PubMed PMID: 30118931.

26: Doruk Camsari D, Kirkovski M, Croarkin PE. Therapeutic Applications of Invasive Neuromodulation in Children and Adolescents. Psychiatr Clin North Am. 2018 Sep;41(3):479-483. doi: 10.1016/j.psc.2018.04.008. Epub 2018 Jul 17. Review. PubMed PMID: 30098659; PubMed Central PMCID: PMC6092040.

27: Lim Z, Wong K, Downs J, Bebbington K, Demarest S, Leonard H. Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder. Epilepsy Res. 2018 Oct;146:36-40. doi: 10.1016/j.eplepsyres.2018.07.013. Epub 2018 Jul 23. PubMed PMID: 30071384.

28: Morrison-Levy N, Go C, Ochi A, Otsubo H, Drake J, Rutka J, Weiss SK. Children with autism spectrum disorders and drug-resistant epilepsy can benefit from epilepsy surgery. Epilepsy Behav. 2018 Aug;85:200-204. doi: 10.1016/j.yebeh.2018.06.023. Epub 2018 Jul 4. PubMed PMID: 30032808.

29: Wheless JW, Gienapp AJ, Ryvlin P. Vagus nerve stimulation (VNS) therapy update. Epilepsy Behav. 2018 Nov;88S:2-10. doi: 10.1016/j.yebeh.2018.06.032. Epub 2018 Jul 13. Review. PubMed PMID: 30017839.

30: Babajani-Feremi A, Noorizadeh N, Mudigoudar B, Wheless JW. Predicting seizure outcome of vagus nerve stimulation using MEG-based network topology. Neuroimage Clin. 2018 Jun 18;19:990-999. doi: 10.1016/j.nicl.2018.06.017. eCollection 2018. PubMed PMID: 30003036; PubMed Central PMCID: PMC6039837.

31: Barbella G, Cocco I, Freri E, Marotta G, Visani E, Franceschetti S, Casazza M. Transcutaneous vagal nerve stimulatio (t-VNS): An adjunctive treatment option for refractory epilepsy. Seizure. 2018 Aug;60:115-119. doi: 10.1016/j.seizure.2018.06.016. Epub 2018 Jun 18. PubMed PMID: 29940349.

32: Aaberg KM, Bakken IJ, Lossius MI, Lund Søraas C, Tallur KK, Stoltenberg C, Chin R, Surén P. Short-term Seizure Outcomes in Childhood Epilepsy. Pediatrics. 2018 Jun;141(6). pii: e20174016. doi: 10.1542/peds.2017-4016. Epub 2018 May 22. PubMed PMID: 29789444.

33: Kumlien E, Hallbook T, Dahlin M. [Treatment with neurostimulation and ketogenic diet for people with medically refractory epilepsy]. Lakartidningen. 2018 May 22;115. pii: E6MD. Swedish. PubMed PMID: 29786802.

34: Fan HC, Hsu TR, Chang KP, Chen SJ, Tsai JD; VNS TCNS. Vagus nerve stimulation for 6- to 12-year-old children with refractory epilepsy: Impact on seizure frequency and parenting stress index. Epilepsy Behav. 2018 Jun;83:119-123. doi: 10.1016/j.yebeh.2017.12.009. Epub 2018 Apr 24. PubMed PMID: 29702412.

35: Arhan E, Serdaroğlu A, Hirfanoğlu T, Kurt G. Aggravation of seizures and status epilepticus after vagal nerve stimulation therapy: the first pediatric case and review of the literature. Childs Nerv Syst. 2018 Sep;34(9):1799-1801. doi: 10.1007/s00381-018-3806-x. Epub 2018 Apr 22. Review. PubMed PMID: 29680919.

36: Welch WP, Sitwat B, Sogawa Y. Use of Vagus Nerve Stimulator on Children With Primary Generalized Epilepsy. J Child Neurol. 2018 Jun;33(7):449-452. doi: 10.1177/0883073818766599. Epub 2018 Apr 13. PubMed PMID: 29651891.

37: Révész D, Fröjd V, Rydenhag B, Ben-Menachem E. Estimating Long-Term Vagus Nerve Stimulation Effectiveness: Accounting for Antiepileptic Drug Treatment Changes. Neuromodulation. 2018 Dec;21(8):797-804. doi: 10.1111/ner.12775. Epub 2018 Apr 2. PubMed PMID: 29608227.

38: Liu HY, Yang Z, Meng FG, Guan YG, Ma YS, Liang SL, Lin JL, Pan LS, Zhao MM, Qu W, Hao HW, Luan GM, Zhang JG, Li LM. Preoperative Heart Rate Variability as Predictors of Vagus Nerve Stimulation Outcome in Patients with Drug-resistant Epilepsy. Sci Rep. 2018 Mar 1;8(1):3856. doi: 10.1038/s41598-018-21669-3. PubMed PMID: 29497072; PubMed Central PMCID: PMC5832772.

39: Gedela S, Sitwat B, Welch WP, Krafty RT, Sogawa Y. The effect of vagus nerve stimulator in controlling status epilepticus in children. Seizure. 2018 Feb;55:66-69. doi: 10.1016/j.seizure.2018.01.010. Epub 2018 Feb 3. PubMed PMID: 29414137.

40: Kokoszka MA, Panov F, La Vega-Talbott M, McGoldrick PE, Wolf SM, Ghatan S. Treatment of medically refractory seizures with responsive neurostimulation: 2 pediatric cases. J Neurosurg Pediatr. 2018 Apr;21(4):421-427. doi: 10.3171/2017.10.PEDS17353. Epub 2018 Feb 2. PubMed PMID: 29393811.

41: Tomei KL, Mau CY, Ghali M, Pak J, Goldstein IM. Vagal nerve stimulation for medically refractory epilepsy in Angelman syndrome: a series of three cases. Childs Nerv Syst. 2018 Mar;34(3):395-400. doi: 10.1007/s00381-018-3723-z. Epub 2018 Jan 19. Review. PubMed PMID: 29350262.

42: Lattanzi S, Cagnetti C, Matricardi S, Silvestrini M. Palliative non-resective surgery for drug-resistant epilepsy. Brain Dev. 2018 Jun;40(6):512-513. doi: 10.1016/j.braindev.2017.12.012. Epub 2018 Jan 17. PubMed PMID: 29342410.

43: Ryvlin P, So EL, Gordon CM, Hesdorffer DC, Sperling MR, Devinsky O, Bunker MT, Olin B, Friedman D. Long-term surveillance of SUDEP in drug-resistant epilepsy patients treated with VNS therapy. Epilepsia. 2018 Mar;59(3):562-572. doi: 10.1111/epi.14002. Epub 2018 Jan 16. PubMed PMID: 29336017.

44: Hosoyama H, Hanaya R, Otsubo T, Sato M, Kashida Y, Sugata S, Katagiri M, Iida K, Arita K. Application of Rubber Band with Hooks on Both Ends for Vagus Nerve Stimulator Implantation. World Neurosurg. 2018 Mar;111:258-260. doi: 10.1016/j.wneu.2017.12.133. Epub 2017 Dec 29. PubMed PMID: 29289803.

45: Grunwald T, Kröll J. [Non-medical options fort her treatment of drug-resistant epilepsies]. Ther Umsch. 2018;75(7):448-454. doi: 10.1024/0040-5930/a001023. Review. German. PubMed PMID: 30935357.

46: Okanishi T, Fujimoto A, Nishimura M, Kanai S, Motoi H, Homma Y, Enoki H. Insufficient efficacy of vagus nerve stimulation for epileptic spasms and tonic spasms in children with refractory epilepsy. Epilepsy Res. 2018 Feb;140:66-71. doi: 10.1016/j.eplepsyres.2017.12.010. Epub 2017 Dec 15. PubMed PMID: 29287185.

47: Uchida D, Yamamoto T, Yamazoe T, Iijima K, Fujimoto A, Enoki H, Tanaka T. [Experience and Solution of Complications of Vagus Nerve Stimulation Therapy in 139 Implant Patients with Medically Refractory Epilepsy]. No Shinkei Geka. 2017 Dec;45(12):1051-1057. doi: 10.11477/mf.1436203646. Japanese. PubMed PMID: 29262385.

48: Soleman J, Knorr C, Datta AN, Strozzi S, Ramelli GP, Mariani L, Guzman R. Early vagal nerve stimulator implantation in children: personal experience and review of the literature. Childs Nerv Syst. 2018 May;34(5):893-900. doi: 10.1007/s00381-017-3694-5. Epub 2017 Dec 18. Review. PubMed PMID: 29255920.

49: Ibrahim GM, Sharma P, Hyslop A, Guillen MR, Morgan BR, Wong S, Abel TJ, Elkaim L, Cajigas I, Shah AH, Fallah A, Weil AG, Altman N, Bernal B, Medina S, Widjaja E, Jayakar P, Ragheb J, Bhatia S. Presurgical thalamocortical connectivity is associated with response to vagus nerve stimulation in children with intractable epilepsy. Neuroimage Clin. 2017 Sep 22;16:634-642. doi: 10.1016/j.nicl.2017.09.015. eCollection 2017. PubMed PMID: 28971013; PubMed Central PMCID: PMC5619991.

50: Kawai K, Tanaka T, Baba H, Bunker M, Ikeda A, Inoue Y, Kameyama S, Kaneko S, Kato A, Nozawa T, Maruoka E, Osawa M, Otsuki T, Tsuji S, Watanabe E, Yamamoto T. Outcome of vagus nerve stimulation for drug-resistant epilepsy: the first three years of a prospective Japanese registry. Epileptic Disord. 2017 Sep 1;19(3):327-338. doi: 10.1684/epd.2017.0929. PubMed PMID: 28832004.

51: Vaiman M, Heyman E, Lotan G. Neurological results of the modified treatment of epilepsy by stimulation of the vagus nerve. Childs Nerv Syst. 2017 Nov;33(11):2017-2022. doi: 10.1007/s00381-017-3490-2. Epub 2017 Jul 8. PubMed PMID: 28689344.

52: Rolston JD, Deng H, Wang DD, Englot DJ, Chang EF. Multiple Subpial Transections for Medically Refractory Epilepsy: A Disaggregated Review of Patient-Level Data. Neurosurgery. 2018 May 1;82(5):613-620. doi: 10.1093/neuros/nyx311. PubMed PMID: 28637175; PubMed Central PMCID: PMC5738293.

53: Alomar S, Mullin JP, Smithason S, Gonzalez-Martinez J. Indications, technique, and safety profile of insular stereoelectroencephalography electrode implantation in medically intractable epilepsy. J Neurosurg. 2018 Apr;128(4):1147-1157. doi: 10.3171/2017.1.JNS161070. Epub 2017 Jun 16. PubMed PMID: 28621621.

54: Li ST, Chiu NC, Kuo YT, Shen EY, Tsai PC, Ho CS, Wu WH, Chen JC; VNS TCNS. Parenting stress in parents of children with refractory epilepsy before and after vagus nerve stimulation implantation. Pediatr Neonatol. 2017 Dec;58(6):516-522. doi: 10.1016/j.pedneo.2017.03.001. Epub 2017 May 17. PubMed PMID: 28566195.

55: Flesler S, Reyes G, Fortini S, Ramos B, Cersosimo R, Bartuluchi M, Caraballo R. [Vagus nerve stimulation: treatment of 158 pediatric patients with a long-term follow-up]. Rev Neurol. 2017 Jun 1;64(11):496-501. Spanish. PubMed PMID: 28555455.

56: Luat AF, Asano E, Kumar A, Chugani HT, Sood S. Corpus Callosotomy for Intractable Epilepsy Revisited: The Children's Hospital of Michigan Series. J Child Neurol. 2017 Jun;32(7):624-629. doi: 10.1177/0883073817697847. Epub 2017 Mar 8. PubMed PMID: 28511630; PubMed Central PMCID: PMC5436305.

57: Liu H, Yang Z, Huang L, Qu W, Hao H, Li L. Heart-rate variability indices as predictors of the response to vagus nerve stimulation in patients with drug-resistant epilepsy. Epilepsia. 2017 Jun;58(6):1015-1022. doi: 10.1111/epi.13738. Epub 2017 Apr 25. PubMed PMID: 28440954.

58: Hong J, Desai A, Thadani VM, Roberts DW. Efficacy and safety of corpus callosotomy after vagal nerve stimulation in patients with drug-resistant epilepsy. J Neurosurg. 2018 Jan;128(1):277-286. doi: 10.3171/2016.10.JNS161841. Epub 2017 Mar 3. PubMed PMID: 28298036.

59: Sourbron J, Klinkenberg S, Kessels A, Schelhaas HJ, Lagae L, Majoie M. Vagus Nerve Stimulation in children: A focus on intellectual disability. Eur J Paediatr Neurol. 2017 May;21(3):427-440. doi: 10.1016/j.ejpn.2017.01.011. Epub 2017 Jan 30. Review. PubMed PMID: 28188025.

60: Hill TC, Rubin BA, Tyagi V, Theobald J, Silverberg A, Miceli M, Dugan P, Carlson C, Doyle WK. The Value of Diagnostic Bilateral Intracranial Electroencephalography in Treatment-Resistant Focal Epilepsy. World Neurosurg. 2017 Jul;103:1-10. doi: 10.1016/j.wneu.2017.01.093. Epub 2017 Feb 7. PubMed PMID: 28185968.

61: Trezza A, Landi A, Grioni D, Pirillo D, Fiori L, Giussani C, Sganzerla EP. Adverse Effects and Surgical Complications in Pediatric Patients Undergoing Vagal Nerve Stimulation for Drug-Resistant Epilepsy. Acta Neurochir Suppl. 2017;124:43-47. doi: 10.1007/978-3-319-39546-3_7. PubMed PMID: 28120051.

62: Wijnen BFM, van Mastrigt GAPG, Evers SMAA, Gershuni O, Lambrechts DAJE, Majoie MHJM, Postulart D, Aldenkamp BAP, de Kinderen RJA. A systematic review of economic evaluations of treatments for patients with epilepsy. Epilepsia. 2017 May;58(5):706-726. doi: 10.1111/epi.13655. Epub 2017 Jan 18. Review. PubMed PMID: 28098939.

63: Fulton SP, Van Poppel K, McGregor AL, Mudigoudar B, Wheless JW. Vagus Nerve Stimulation in Intractable Epilepsy Associated With SCN1A Gene Abnormalities. J Child Neurol. 2017 Apr;32(5):494-498. doi: 10.1177/0883073816687221. Epub 2017 Jan 12. PubMed PMID: 28079431.

64: Englot DJ, Hassnain KH, Rolston JD, Harward SC, Sinha SR, Haglund MM. Quality-of-life metrics with vagus nerve stimulation for epilepsy from provider survey data. Epilepsy Behav. 2017 Jan;66:4-9. doi: 10.1016/j.yebeh.2016.10.005. Epub 2016 Dec 11. PubMed PMID: 27974275; PubMed Central PMCID: PMC5258831.

65: Baba S, Sugawara Y, Moriyama K, Inaji M, Maehara T, Yamamoto T, Morio T. Amelioration of intractable epilepsy by adjunct vagus nerve stimulation therapy in a girl with a CDKL5 mutation. Brain Dev. 2017 Apr;39(4):341-344. doi: 10.1016/j.braindev.2016.10.007. Epub 2016 Nov 4. PubMed PMID: 27823948.

66: Kim MJ, Yum MS, Kim EH, Lee YJ, Lee J, Hong S, You SJ, Hwang YS, Ko TS. An interictal EEG can predict the outcome of vagus nerve stimulation therapy for children with intractable epilepsy. Childs Nerv Syst. 2017 Jan;33(1):145-151. doi: 10.1007/s00381-016-3261-5. Epub 2016 Oct 6. PubMed PMID: 27714458.

67: Ralston A, Ogden P, Kohrman MH, Frim DM. In situ repair of vagus nerve stimulator lead damage: technical note. J Neurosurg Pediatr. 2016 Dec;25(6):679-682. Epub 2016 Sep 9. PubMed PMID: 27611900.

68: Fallah A, Weil AG, Wang S, Lewis E, Baca CB, Mathern GW. Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex. Epilepsy Behav. 2016 Oct;63:79-88. doi: 10.1016/j.yebeh.2016.07.034. Epub 2016 Aug 31. PubMed PMID: 27591681.

69: Bartolomei F, Bonini F, Vidal E, Trébuchon A, Lagarde S, Lambert I, McGonigal A, Scavarda D, Carron R, Benar CG. How does vagal nerve stimulation (VNS) change EEG brain functional connectivity? Epilepsy Res. 2016 Oct;126:141-6. doi: 10.1016/j.eplepsyres.2016.06.008. Epub 2016 Jul 29. PubMed PMID: 27497814.

70: Fuentes-Pita P, Gomez-Lado C, Dacruz D, Eiris-Punal J, Prieto-Gonzalez A, Castro-Gago M. [Retrospective analysis of the effect of a vagus nerve stimulator implanted in paediatric patients with refractory epilepsy]. Rev Neurol. 2016 Jul 1;63(1):11-8. Spanish. PubMed PMID: 27345275.

71: Guan J, Karsy M, Ducis K, Bollo RJ. Surgical strategies for pediatric epilepsy. Transl Pediatr. 2016 Apr;5(2):55-66. doi: 10.21037/tp.2016.03.02. Review. PubMed PMID: 27186522; PubMed Central PMCID: PMC4855198.

72: Carosella CM, Greiner HM, Byars AW, Arthur TM, Leach JL, Turner M, Holland KD, Mangano FT, Arya R. Vagus Nerve Stimulation for Electrographic Status Epilepticus in Slow-Wave Sleep. Pediatr Neurol. 2016 Jul;60:66-70. doi: 10.1016/j.pediatrneurol.2016.02.016. Epub 2016 Mar 4. PubMed PMID: 27068060.

73: Cantarín-Extremera V, Ruíz-Falcó-Rojas ML, Tamaríz-Martel-Moreno A, García-Fernández M, Duat-Rodriguez A, Rivero-Martín B. Late-onset periodic bradycardia during vagus nerve stimulation in a pediatric patient. A new case and review of the literature. Eur J Paediatr Neurol. 2016 Jul;20(4):678-83. doi: 10.1016/j.ejpn.2016.02.014. Epub 2016 Mar 16. Review. PubMed PMID: 27056279.

74: Révész D, Rydenhag B, Ben-Menachem E. Complications and safety of vagus nerve stimulation: 25 years of experience at a single center. J Neurosurg Pediatr. 2016 Jul;18(1):97-104. doi: 10.3171/2016.1.PEDS15534. Epub 2016 Mar 25. PubMed PMID: 27015521.

75: Katagiri M, Iida K, Kagawa K, Hashizume A, Ishikawa N, Hanaya R, Arita K, Kurisu K. Combined surgical intervention with vagus nerve stimulation following corpus callosotomy in patients with Lennox-Gastaut syndrome. Acta Neurochir (Wien). 2016 May;158(5):1005-12. doi: 10.1007/s00701-016-2765-9. Epub 2016 Mar 15. PubMed PMID: 26979179.

76: Kossoff EH, Doerrer SC, Winesett SP, Turner Z, Henry BJ, Bessone S, Stanfield A, Cervenka MC. Diet Redux: Outcomes from Reattempting Dietary Therapy for Epilepsy. J Child Neurol. 2016 Jul;31(8):1052-6. doi: 10.1177/0883073816636225. Epub 2016 Mar 9. PubMed PMID: 26961268.

77: Bodin E, Le Moing AG, Bourel-Ponchel E, Querne L, Toussaint P, Berquin P. Vagus nerve stimulation in the treatment of drug-resistant epilepsy in 29 children. Eur J Paediatr Neurol. 2016 May;20(3):346-51. doi: 10.1016/j.ejpn.2016.01.011. Epub 2016 Feb 8. PubMed PMID: 26922364.

78: Tsai JD, Chang YC, Lin LC, Hung KL; VNS TCNS. The neuropsychological outcome of pediatric patients with refractory epilepsy treated with VNS–A 24-month follow-up in Taiwan. Epilepsy Behav. 2016 Mar;56:95-8. doi: 10.1016/j.yebeh.2015.12.030. Epub 2016 Feb 4. PubMed PMID: 26851647.

79: Serdaroglu A, Arhan E, Kurt G, Erdem A, Hirfanoglu T, Aydin K, Bilir E. Long term effect of vagus nerve stimulation in pediatric intractable epilepsy: an extended follow-up. Childs Nerv Syst. 2016 Apr;32(4):641-6. doi: 10.1007/s00381-015-3004-z. Epub 2016 Jan 15. PubMed PMID: 26767841.

80: Burke T, Hughes D, Forsey J, Bunker M, Bhattacharya D, Smithson WH. A study of the impact of VNS on health care utilisation in England. Seizure. 2016 Jan;34:12-7. doi: 10.1016/j.seizure.2015.11.002. Epub 2015 Nov 14. PubMed PMID: 26615578.

81: Toupin JF, Lortie A, Major P, Diadori P, Vanasse M, Rossignol E, D'Anjou G, Perreault S, Larbrisseau A, Carmant L, Birca A. Efficacy and safety of lacosamide as an adjunctive therapy for refractory focal epilepsy in paediatric patients: a retrospective single-centre study. Epileptic Disord. 2015 Dec;17(4):436-43. doi: 10.1684/epd.2015.0782. PubMed PMID: 26609635.

82: Guerrini R, Duchowny M, Jayakar P, Krsek P, Kahane P, Tassi L, Melani F, Polster T, Andre VM, Cepeda C, Krueger DA, Cross JH, Spreafico R, Cosottini M, Gotman J, Chassoux F, Ryvlin P, Bartolomei F, Bernasconi A, Stefan H, Miller I, Devaux B, Najm I, Giordano F, Vonck K, Barba C, Blumcke I. Diagnostic methods and treatment options for focal cortical dysplasia. Epilepsia. 2015 Nov;56(11):1669-86. doi: 10.1111/epi.13200. Epub 2015 Oct 5. Review. PubMed PMID: 26434565.

83: Meng FG, Jia FM, Ren XH, Ge Y, Wang KL, Ma YS, Ge M, Zhang K, Hu WH, Zhang X, Hu W, Zhang JG. Vagus Nerve Stimulation for Pediatric and Adult Patients with Pharmaco-resistant Epilepsy. Chin Med J (Engl). 2015 Oct 5;128(19):2599-604. doi: 10.4103/0366-6999.166023. PubMed PMID: 26415797; PubMed Central PMCID: PMC4736866.

84: Lagae L, Verstrepen A, Nada A, Van Loon J, Theys T, Ceulemans B, Jansen K. Vagus nerve stimulation in children with drug-resistant epilepsy: age at implantation and shorter duration of epilepsy as predictors of better efficacy? Epileptic Disord. 2015 Sep;17(3):308-14. doi: 10.1684/epd.2015.0768. PubMed PMID: 26271818.

85: Galbarriatu L, Pomposo I, Aurrecoechea J, Marinas A, Agúndez M, Gómez JC, Acera MA, Martínez MJ, Valle E, Maestro I, Mateos B, Cabrera A, Fernández J, Iturri F, Garamendi I. Vagus nerve stimulation therapy for treatment-resistant epilepsy: a 15-year experience at a single institution. Clin Neurol Neurosurg. 2015 Oct;137:89-93. doi: 10.1016/j.clineuro.2015.06.023. Epub 2015 Jul 2. PubMed PMID: 26164349.

86: Al-Said Y, Baeesa S, Khalid M, Abdeen M, Kayyali HR. Vagus nerve stimulation for refractory epilepsy: experience from Saudi Arabia. Ann Saudi Med. 2015 Jan-Feb;35(1):41-5. doi: 10.5144/0256-4947.2015.41. PubMed PMID: 26142937; PubMed Central PMCID: PMC6152542.

87: Panebianco M, Rigby A, Weston J, Marson AG. Vagus nerve stimulation for partial seizures. Cochrane Database Syst Rev. 2015 Apr 3;(4):CD002896. doi: 10.1002/14651858.CD002896.pub2. Review. PubMed PMID: 25835947.

88: Bindra A, Chouhan RS, Prabhakar H, Chandra PS, Tripathi M. Perioperative anesthetic implications of epilepsy surgery: a retrospective analysis. J Anesth. 2015 Apr;29(2):229-34. doi: 10.1007/s00540-014-1919-2. Epub 2014 Oct 7. PubMed PMID: 25288505.

89: Orosz I, McCormick D, Zamponi N, Varadkar S, Feucht M, Parain D, Griens R, Vallée L, Boon P, Rittey C, Jayewardene AK, Bunker M, Arzimanoglou A, Lagae L. Vagus nerve stimulation for drug-resistant epilepsy: a European long-term study up to 24 months in 347 children. Epilepsia. 2014 Oct;55(10):1576-84. doi: 10.1111/epi.12762. Epub 2014 Sep 17. PubMed PMID: 25231724.

90: Klinkenberg S, van den Borne CJ, Aalbers MW, Verschuure P, Kessels AG, Leenen L, Rijkers K, Aldenkamp AP, Vles JS, Majoie HJ. The effects of vagus nerve stimulation on tryptophan metabolites in children with intractable epilepsy. Epilepsy Behav. 2014 Aug;37:133-8. doi: 10.1016/j.yebeh.2014.06.001. Epub 2014 Jul 10. PubMed PMID: 25022821.

91: Parakh M, Katewa V. Non-pharmacologic management of epilepsy. Indian J Pediatr. 2014 Oct;81(10):1073-80. doi: 10.1007/s12098-014-1519-z. Epub 2014 Jul 5. Review. PubMed PMID: 24997144.

92: Ulate-Campos A, Cean-Cabrera L, Petanas-Argemi J, García-Fructuoso G, Aparicio J, López-Sala A, Palacio-Navarro A, Mas MJ, Muchart J, Rebollo M, Sanmartí FX. Vagus nerve stimulator implantation for epilepsy in a paediatric hospital: outcomes and effect on quality of life. Neurologia. 2015 Oct;30(8):465-71. doi: 10.1016/j.nrl.2014.04.014. Epub 2014 Jun 26. English, Spanish. PubMed PMID: 24975345.

93: Puertas-Martin V, Carreras-Saez I, Marana A, Ruiz-Falco Rojas ML, Cantarin-Extremera V, Calleja-Gero ML. [Therapeutic possibilities in refractory epilepsy in tuberous sclerosis complex]. Rev Neurol. 2014 Jun 16;58(12):529-35. Spanish. PubMed PMID: 24915028.

94: Menascu S, Kremer U, Schiller Y, Blatt I, Watemberg N, Boxer M, Goldberg H, Korn-Lubetzki I, Steinberg M, Ben-Zeev B. The Israeli retrospective multicenter open-label study evaluating vagus nerve stimulation efficacy in children and adults. Isr Med Assoc J. 2013 Nov;15(11):673-7. PubMed PMID: 24511646.

95: Chambers A, Bowen JM. Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis. Ont Health Technol Assess Ser. 2013 Oct 1;13(18):1-37. eCollection 2013. Review. PubMed PMID: 24228081; PubMed Central PMCID: PMC3817921.

96: Terra VC, Furlanetti LL, Nunes AA, Thomé U, Nisyiama MA, Sakamoto AC, Machado HR. Vagus nerve stimulation in pediatric patients: Is it really worthwhile? Epilepsy Behav. 2014 Feb;31:329-33. doi: 10.1016/j.yebeh.2013.10.011. Epub 2013 Nov 5. PubMed PMID: 24210463.

97: De Benedictis A, Freri E, Rizzi M, Franzini A, Ragona F, Specchio N, Rebessi E, Casazza M, Granata T, Marras CE. Vagus nerve stimulation for drug-resistant Epilepsia Partialis Continua: report of four cases. Epilepsy Res. 2013 Nov;107(1-2):163-71. doi: 10.1016/j.eplepsyres.2013.07.010. Epub 2013 Sep 8. PubMed PMID: 24074541.

98: Kahlow H, Olivecrona M. Complications of vagal nerve stimulation for drug-resistant epilepsy: a single center longitudinal study of 143 patients. Seizure. 2013 Dec;22(10):827-33. doi: 10.1016/j.seizure.2013.06.011. Epub 2013 Jul 15. PubMed PMID: 23867218.

99: Benedetti-Isaac JC, Torres-Zambrano M, Alcalá-Cerra G, Gutiérrez-Paternina JJ. Vagus nerve stimulation for drug-resistant epilepsy in a patient with Mowat-Wilson syndrome. Neurol India. 2013 May-Jun;61(3):306-7. doi: 10.4103/0028-3886.115074. PubMed PMID: 23860154.

100: Usami K, Kawai K, Sonoo M, Saito N. Scalp-recorded evoked potentials as a marker for afferent nerve impulse in clinical vagus nerve stimulation. Brain Stimul. 2013 Jul;6(4):615-23. doi: 10.1016/j.brs.2012.09.007. Epub 2012 Oct 11. PubMed PMID: 23088852.

101: Colicchio G, Montano N, Fuggetta F, Papacci F, Signorelli F, Meglio M. Vagus nerve stimulation in drug-resistant epilepsies. Analysis of potential prognostic factors in a cohort of patients with long-term follow-up. Acta Neurochir (Wien). 2012 Dec;154(12):2237-40. doi: 10.1007/s00701-012-1524-9. Epub 2012 Oct 21. PubMed PMID: 23086106.

102: Bao M, Zhou J, Luan GM. Treatment of drug-resistant epilepsy with vagus nerve stimulation – review of 45 cases. Chin Med J (Engl). 2011 Dec;124(24):4184-8. PubMed PMID: 22340384.

103: Shigeto H. [An adult neurologist's update on epilepsy therapy]. Rinsho Shinkeigaku. 2011 Nov;51(11):997-9. Review. Japanese. PubMed PMID: 22277455.

104: Helmers SL, Duh MS, Guérin A, Sarda SP, Samuelson TM, Bunker MT, Olin BD, Jackson SD, Faught E. Clinical outcomes, quality of life, and costs associated with implantation of vagus nerve stimulation therapy in pediatric patients with drug-resistant epilepsy. Eur J Paediatr Neurol. 2012 Sep;16(5):449-58. doi: 10.1016/j.ejpn.2012.01.001. Epub 2012 Jan 18. PubMed PMID: 22261080.

105: Majkowska-Zwolińska B, Zwoliński P, Roszkowski M, Drabik K. Long-term results of vagus nerve stimulation in children and adolescents with drug-resistant epilepsy. Childs Nerv Syst. 2012 Apr;28(4):621-8. doi: 10.1007/s00381-011-1670-z. Epub 2012 Jan 6. PubMed PMID: 22222361.

106: Guilhoto LM, Loddenkemper T, Gooty VD, Rotenberg A, Takeoka M, Duffy FH, Coulter D, Urion D, Bourgeois BF, Kothare SV. Experience with lacosamide in a series of children with drug-resistant focal epilepsy. Pediatr Neurol. 2011 Jun;44(6):414-9. doi: 10.1016/j.pediatrneurol.2010.12.003. PubMed PMID: 21555051.

107: Elliott RE, Rodgers SD, Bassani L, Morsi A, Geller EB, Carlson C, Devinsky O, Doyle WK. Vagus nerve stimulation for children with treatment-resistant epilepsy: a consecutive series of 141 cases. J Neurosurg Pediatr. 2011 May;7(5):491-500. doi: 10.3171/2011.2.PEDS10505. PubMed PMID: 21529189.

108: Kawai K. [Vagus nerve stimulation therapy for epilepsy]. Brain Nerve. 2011 Apr;63(4):331-46. Review. Japanese. PubMed PMID: 21441636.

109: Zamponi N, Passamonti C, Cesaroni E, Trignani R, Rychlicki F. Effectiveness of vagal nerve stimulation (VNS) in patients with drop-attacks and different epileptic syndromes. Seizure. 2011 Jul;20(6):468-74. doi: 10.1016/j.seizure.2011.02.011. Epub 2011 Mar 10. PubMed PMID: 21396833.

110: Elliott RE, Morsi A, Tanweer O, Grobelny B, Geller E, Carlson C, Devinsky O, Doyle WK. Efficacy of vagus nerve stimulation over time: review of 65 consecutive patients with treatment-resistant epilepsy treated with VNS > 10 years. Epilepsy Behav. 2011 Mar;20(3):478-83. doi: 10.1016/j.yebeh.2010.12.042. Epub 2011 Feb 5. PubMed PMID: 21296622.

111: Elliott RE, Morsi A, Kalhorn SP, Marcus J, Sellin J, Kang M, Silverberg A, Rivera E, Geller E, Carlson C, Devinsky O, Doyle WK. Vagus nerve stimulation in 436 consecutive patients with treatment-resistant epilepsy: long-term outcomes and predictors of response. Epilepsy Behav. 2011 Jan;20(1):57-63. doi: 10.1016/j.yebeh.2010.10.017. Epub 2010 Dec 8. PubMed PMID: 21144802.

112: Franzoni E, Gentile V, Colonnelli MC, Brunetto D, Cecconi I, Iero L, Moscano FC, Cordelli DM, Marchiani V. VNS in drug resistant epilepsy: preliminary report on a small group of patients. Ital J Pediatr. 2010 Apr 14;36:30. doi: 10.1186/1824-7288-36-30. PubMed PMID: 20398284; PubMed Central PMCID: PMC2859348.

113: Colicchio G, Policicchio D, Barbati G, Cesaroni E, Fuggetta F, Meglio M, Papacci F, Rychlicki F, Scerrati M, Zamponi N. Vagal nerve stimulation for drug-resistant epilepsies in different age, aetiology and duration. Childs Nerv Syst. 2010 Jun;26(6):811-9. doi: 10.1007/s00381-009-1069-2. Epub 2010 Jan 21. PubMed PMID: 20091042.

114: Wheless JW. Managing severe epilepsy syndromes of early childhood. J Child Neurol. 2009 Aug;24(8 Suppl):24S-32S; quiz 33S-6S. doi: 10.1177/0883073809338153. Review. PubMed PMID: 19666880.

115: Yu ZJ, Weller RA, Sandidge K, Weller EB. Vagus nerve stimulation: can it be used in adolescents or children with treatment-resistant depression? Curr Psychiatry Rep. 2008 Apr;10(2):116-22. Review. PubMed PMID: 18474201.

116: Bulteau C, Dorfmüller G, Fohlen M, Jalin C, Oliver MV, Delalande O. [Epilepsy surgery during infancy and early childhood in France]. Neurochirurgie. 2008 May;54(3):342-6. doi: 10.1016/j.neuchi.2008.02.026. Epub 2008 Apr 23. French. PubMed PMID: 18436266.

117: Danielsson S, Viggedal G, Gillberg C, Olsson I. Lack of effects of vagus nerve stimulation on drug-resistant epilepsy in eight pediatric patients with autism spectrum disorders: a prospective 2-year follow-up study. Epilepsy Behav. 2008 Feb;12(2):298-304. Epub 2007 Nov 28. PubMed PMID: 18053767.

118: Kostov H, Larsson PG, Røste GK. Is vagus nerve stimulation a treatment option for patients with drug-resistant idiopathic generalized epilepsy? Acta Neurol Scand Suppl. 2007;187:55-8. PubMed PMID: 17419830.

119: Rauchenzauner M, Haberlandt E, Högler W, Luef G. Brain-type natriuretic peptide release and seizure activity during vagal nerve stimulation. Epilepsia. 2007 Feb;48(2):397-9. PubMed PMID: 17295638.

120: Rychlicki F, Zamponi N, Trignani R, Ricciuti RA, Iacoangeli M, Scerrati M. Vagus nerve stimulation: clinical experience in drug-resistant pediatric epileptic patients. Seizure. 2006 Oct;15(7):483-90. Epub 2006 Aug 8. PubMed PMID: 16899378.

121: Benifla M, Rutka JT, Logan W, Donner EJ. Vagal nerve stimulation for refractory epilepsy in children: indications and experience at The Hospital for Sick Children. Childs Nerv Syst. 2006 Aug;22(8):1018-26. Epub 2006 Jul 1. Review. PubMed PMID: 16816981.

122: Bremer A, Eriksson AS, Røste GK, Knudtzen B, Nakken KO. [Vagal nerve stimulation in children with drug-resistant epilepsy]. Tidsskr Nor Laegeforen. 2006 Mar 23;126(7):896-8. Norwegian. PubMed PMID: 16554878.

123: Rychlicki F, Zamponi N, Cesaroni E, Corpaci L, Trignani R, Ducati A, Scerrati M. Complications of vagal nerve stimulation for epilepsy in children. Neurosurg Rev. 2006 Apr;29(2):103-7. Epub 2006 Feb 18. PubMed PMID: 16518639.

124: Hallböök T, Lundgren J, Köhler S, Blennow G, Strömblad LG, Rosén I. Beneficial effects on sleep of vagus nerve stimulation in children with therapy resistant epilepsy. Eur J Paediatr Neurol. 2005;9(6):399-407. Epub 2005 Oct 28. PubMed PMID: 16257548.

125: Hallböök T, Lundgren J, Stjernqvist K, Blennow G, Strömblad LG, Rosén I. Vagus nerve stimulation in 15 children with therapy resistant epilepsy; its impact on cognition, quality of life, behaviour and mood. Seizure. 2005 Oct;14(7):504-13. Epub 2005 Sep 19. PubMed PMID: 16176878.

126: Zwoliński P, Roszkowski M, Drabik K, Baczuk L, Majkowski J. [Vagus nerve stimulation in drug-resistant epilepsy. Experience with 23 patients]. Neurol Neurochir Pol. 2004 May-Jun;38(3):161-9; discussion 170-1. Polish. PubMed PMID: 15354227.

127: Buoni S, Mariottini A, Pieri S, Zalaffi A, Farnetani MA, Strambi M, Palma L, Fois A. Vagus nerve stimulation for drug-resistant epilepsy in children and young adults. Brain Dev. 2004 Apr;26(3):158-63. PubMed PMID: 15030903.

128: Polkey CE. Clinical outcome of epilepsy surgery. Curr Opin Neurol. 2004 Apr;17(2):173-8. Review. PubMed PMID: 15021245.

129: Hosain SA, Green NS, Solomon GE, Chutorian A. Nitrazepam for the treatment of Lennox-Gastaut syndrome. Pediatr Neurol. 2003 Jan;28(1):16-9. PubMed PMID: 12657414.

130: Forcadas-Berdusán MI. [Indications and results of nonpharmacological treatments of epilepsies: vagal stimulation, ketogenic diet and gamma rays]. Rev Neurol. 2002 Sep;35 Suppl 1:S144-50. Spanish. PubMed PMID: 12373666.

131: Iriarte J, Urrestarazu E, L zaro D, Schlumberger E. [Vagal stimulation in the treatment of epilepsy]. Rev Neurol. 2002 Mar 16-31;34(6):511-8. Spanish. PubMed PMID: 12040494.

132: Zamponi N, Rychlicki F, Cardinali C, Luchetti A, Trignani R, Ducati A. Intermittent vagal nerve stimulation in paediatric patients: 1-year follow-up. Childs Nerv Syst. 2002 Feb;18(1-2):61-6. Epub 2002 Jan 24. PubMed PMID: 11935246.

133: Privitera MD, Welty TE, Ficker DM, Welge J. Vagus nerve stimulation for partial seizures. Cochrane Database Syst Rev. 2002;(1):CD002896. Review. Update in: Cochrane Database Syst Rev. 2015;4:CD002896. PubMed PMID: 11869641.

134: Majoie HJ, Berfelo MW, Aldenkamp AP, Evers SM, Kessels AG, Renier WO. Vagus nerve stimulation in children with therapy-resistant epilepsy diagnosed as Lennox-Gastaut syndrome: clinical results, neuropsychological effects, and cost-effectiveness. J Clin Neurophysiol. 2001 Sep;18(5):419-28. PubMed PMID: 11709647.

135: Spatt J, Pelzl G, Mamoli B, Zartl M. [Current problems in epilepsy]. Wien Klin Wochenschr. 1999 Sep 17;111(17):705-12. Review. German. PubMed PMID: 10526394.

136: Labar D, Murphy J, Tecoma E. Vagus nerve stimulation for medication-resistant generalized epilepsy. E04 VNS Study Group. Neurology. 1999 Apr 22;52(7):1510-2. PubMed PMID: 10227649.


1)
Jian L, Ju-Bo W, Yu Q, Shou-Ping G. A Novel Scoring System to Evaluate the Efficacy of Vagus Nerve Stimulation for Pediatric Drug-Resistant Epilepsy. J Child Neurol. 2020 Mar;35(4):297-299. doi: 10.1177/0883073819891263. Epub 2019 Dec 16. PubMed PMID: 31838932.
2)
Wang HJ, Tan G, Zhu LN, Chen D, Xu D, Chu SS, Liu L. Predictors of seizure reduction outcome after vagus nerve stimulation in drug-resistant epilepsy. Seizure. 2019 Mar;66:53-60. doi: 10.1016/j.seizure.2019.02.010. Epub 2019 Feb 15. PubMed PMID: 30802843.
3)
Kavčič A, Kajdič N, Rener-Primec Z, Krajnc N, Žgur T. Efficacy and tolerability of vagus nerve stimulation therapy (VNS) in Slovenian epilepsy patients: younger age and shorter duration of epilepsy might result in better outcome. Acta Clin Croat. 2019 Jun;58(2):255-264. doi: 10.20471/acc.2019.58.02.08. PubMed PMID: 31819321; PubMed Central PMCID: PMC6884381.
4)
Park HR, Choi SJ, Joo EY, Seo DW, Hong SB, Lee JI, Hong SC, Lee S, Shon YM. The Role of Anterior Thalamic Deep Brain Stimulation as an Alternative Therapy in Patients with Previously Failed Vagus Nerve Stimulation for Refractory Epilepsy. Stereotact Funct Neurosurg. 2019;97(3):176-182. doi: 10.1159/000502344. Epub 2019 Sep 18. PubMed PMID: 31533117.
5)
Ji T, Yang Z, Liu Q, Liao J, Yin F, Chen Y, Zou L, Li B, Gao Y, Shu X, Huang S, Gao F, Liang J, Lin SF, Peng J, Song S, Wang J, Che C, Sun W, Tian M, Yang L, Hua Y, Hao Y, Cai L, Li L, Jiang Y. Vagus nerve stimulation for pediatric patients with intractable epilepsy between 3 and 6 years of age: study protocol for a double-blind, randomized control trial. Trials. 2019 Jan 14;20(1):44. doi: 10.1186/s13063-018-3087-4. PubMed PMID: 30642370; PubMed Central PMCID: PMC6332620.
6)
Serino D, Davico C, Specchio N, Marras CE, Fioretto F. Berardinelli-Seip syndrome and progressive myoclonus epilepsy. Epileptic Disord. 2019 Feb 1;21(1):117-121. doi: 10.1684/epd.2019.1038. PubMed PMID: 30767895.
  • vagus_nerve_stimulation_for_drug-resistant_epilepsy_in_children.txt
  • Last modified: 2020/04/11 11:28
  • by administrador